<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04988503</url>
  </required_header>
  <id_info>
    <org_study_id>B-2012/652-002</org_study_id>
    <nct_id>NCT04988503</nct_id>
  </id_info>
  <brief_title>Bare Platinum Coils Versus Second-generation Hydrocoils</brief_title>
  <official_title>Bare Platinum Coils Versus Second-generation Hydrocoils for the Endovascular Treatment of Ruptured Intracranial Aneurysms: a Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pusan National University Yangsan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chungnam National University Sejong Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of clinical and radiological outcomes between bare platinum coil group and&#xD;
      second-generation hydrogel coils for treatment of ruptured intracranial aneurysms.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators aimed to analyze whether the use of second-generation hydrogel coils for&#xD;
      the treatment of ruptured intracranial aneurysms improves clinical and angiographic outcomes&#xD;
      compared with the use of bare platinum coils.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 23, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>bare platinum coils group versus second-generation hydrogel coil group</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>recurrence rate after treatment</measure>
    <time_frame>during 12 months after coil embolization</time_frame>
    <description>recurrence rate at 12 months after coil embolization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rates of thromboembolic and hemorrhagic complications</measure>
    <time_frame>during 12 months after coil embolization</time_frame>
    <description>Rates of thromboembolic and hemorrhagic complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of periprocedural complications</measure>
    <time_frame>within 30 days after coil embolization</time_frame>
    <description>Rate of periprocedural complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of clinical outcomes using modified Rankin Scale scores</measure>
    <time_frame>during 12 months after coil embolization</time_frame>
    <description>Modified Rankin Scale scores (0-6, higher scores mean a worse outcome)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">118</enrollment>
  <condition>Aneurysm, Ruptured</condition>
  <condition>Intracranial Aneurysm</condition>
  <arm_group>
    <arm_group_label>Second-generation hydrogel coil group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment using second-generation hydrogel coils (had to constitute &gt; 50% of the total coil length) for ruptured cerebral aneurysms</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bare platinum coil group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment using bare metal coil only for ruptured cerebral aneurysms</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Coil embolization</intervention_name>
    <description>coil embolization for ruptured intracranial aneurysm with bare platinum coils or second-generation hydrogel coils</description>
    <arm_group_label>Bare platinum coil group</arm_group_label>
    <arm_group_label>Second-generation hydrogel coil group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  19 year old or older&#xD;
&#xD;
          -  untreated ruptured intracranial aneurysms with an anatomy such that endovascular&#xD;
             treatment with either bare platinum or second-generation hydrogel coils was considered&#xD;
             feasible.&#xD;
&#xD;
          -  person who agreed to study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  contrast allgery (+)&#xD;
&#xD;
          -  combined other intracranial lesions (tumor, moyamoya disease, cerebral vascular&#xD;
             diseases)&#xD;
&#xD;
          -  ineligible for coil embolization&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>O-Ki Kwon</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Seung Pil Ban</last_name>
    <phone>81-31-787-7175</phone>
    <email>neurosurgeryban@gmail.com</email>
  </overall_contact>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 23, 2021</study_first_submitted>
  <study_first_submitted_qc>July 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 3, 2021</study_first_posted>
  <last_update_submitted>August 16, 2021</last_update_submitted>
  <last_update_submitted_qc>August 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>aneurysms</keyword>
  <keyword>embolization</keyword>
  <keyword>rupture</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intracranial Aneurysm</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aneurysm, Ruptured</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

